Издательство РАДИОТЕХНИКА

A.A. Valueva – Junior Research Scientist, Institute of Biomedical Chemistry (Moscow); D. Mendeleev University of Chemical Technology of Russia (Moscow)

E-mail: varuevavarueva@gmail.com

R.A. Galiullin – Lead Programmer, Institute of Biomedical Chemistry (Moscow)

E-mail: rafael.anvarovich@gmail.com

V.S. Ziborov – Leading Specialist, Institute of Biomedical Chemistry (Moscow); Joint Institute for High Temperatures of the RAS (Moscow)

E-mail: ziborov.vs@yandex.ru

O.F. Petrov – Academician of the RAS, Dr.Sc. (Phys.-Math.), Director of the Institute,

Joint Institute for High Temperatures of the RAS (Moscow)

E-mail: ofpetrov@ihed.ras.ru

V.G. Nikitaev – Dr.Sc. (Eng.), Professor, Head of the Department of computer medical system, National Research Nuclear University «MEPhI» (Moscow)

E-mail: kaf46@mail.ru

A.N. Pronichev – Ph.D. (Eng.), First Deputy Head of the Department of Computer Medical Systems, National Research Nuclear University «MEPhI» (Moscow)

E-mail: kaf46@mail.ru

E.A. Druzhinina – Post-graduate Student, National Research Nuclear University «MEPhI» (Moscow)

E-mail: kaf46@mail.ru

Yu.D. Ivanov – Dr.Sc. (Biol.), Professor, Head of the Nanobiotechnology Laboratory,

Institute of Biomedical Chemistry (Moscow)

E-mail: yurii.ivanov.nata@gmail.com

Analysis of methylation levels of miRNA genes in tumors and metastases, taking into account the concentrations of VEGF in the blood plasma of patients with ovarian cancer

V.I. Loginov1, I.V. Tereshkina2, D.N. Kushlinsky3, A.A. Alferov4, A.I. Koltunova5, N.A. Arzhanukhina6, D.V. Rogozhin7, E.A. Braga8, O.V. Kovaleva9, N.E. Kushlinskii10

1,4,8,10 Research Institute of General Pathology and Pathophysiology (Moscow, Russia)

2 A.I. Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of Russia
(Moscow, Russia)

3 Institute for advanced training of healthcare professionals of the Ministry of Health of the Khabarovsk Territory (Khabarovsk, Russia)

4–7,9,10 N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia (Moscow, Russia)

miRNAs in the regulation of the PD-1/PD-L1 immune checkpoint in ovarian cancer

D.O. Utkin1, V.I. Loginov2, D.N. Kushlinsky3, N.Yu. Sokolov4, A.I. Koltunova5, N.A. Arzhanukhina6, D.V. Rogozhin7, J.G. Pajanidi8, E.A. Braga9

1,4–8 Blokhin National Medical Research Center of Oncology,
Ministry of Health of the Russian Federation (Moscow, Russia)

1 Moscow City Oncology Hospital №62 (Moscow, Russia)

2,9 Institute of General Pathology and Pathophysiology (Moscow, Russia)

3 Institute for advanced training of healthcare professionals of the Ministry of Health
of the Khabarovsk Territory (Khabarovsk, Russia)